Protagenic Therapeutics, Inc. (OTCPK: PTIX)
Health Care · Biotechnology · US
$0.75
-2.60% today · -76.6% 1Y
Protagenic Therapeutics, Inc. (OTCPK: PTIX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.36M and employs 2 people.
Over the last twelve months the share price has lost 76.6%, trading between 0.13 and 3.32.
Tweenvest scores Protagenic Therapeutics, Inc. across four factors: quality 37/100, value 36/100. Its strongest factor is quality.
PTIX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.36M
- Revenue (TTM)
- —
- P/E
- 0.25
- EPS
- 2.94
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $3.32
- 52-week low
- $0.13
- Avg volume (3M)
- —
- Shares outstanding
- 1.81M
- Employees
- 2
- Next earnings
- —
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.
- ISIN
- US74365N3017
- Founded
- 2004
- Listed since
- Apr 27, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioSenic S.A.ENXTBR: BIOS | $1.47M | €0.00 | -9.09% |
| Hexima LimitedASX: HXL | $1.44M | AU$— | — |
| NKGen Biotech, Inc.OTCPK: NKGN | $1.44M | $0.01 | -0.90% |
| Lakewood-Amedex Biotherapeutics, Inc.NasdaqCM: LABT | $1.37M | $0.58 | -25.85% |
| Premier Biomedical, Inc.OTCPK: BIEI | $1.25M | $0.00 | +5.71% |
| AXIM Biotechnologies, Inc.OTCPK: AXIM | $1.23M | $0.00 | -1.31% |
| Bone Biologics CorporationNasdaqCM: BBLG | $1.09M | $0.40 | -15.44% |
| Valion Bio, Inc.NasdaqCM: VBIO | $1.04M | $1.17 | -45.33% |
Figures last refreshed Oct 18, 2026.